Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.
Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM). In the first trial, a small pilot study ...
Instead, azithromycin or erythromycin, both macrolide antibiotics, can be used to treat Campylobacter infections. Azithromycin can also be used as a last resort to treat Salmonella infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results